New service leverages proprietary technology to provide unprecedented insights into antibody autoreactivity for translational research and therapeutic development.
Read More
Resources
News
Stay current with our recent news, updates, and announcements.
Infinity Bio, Inc. is proud to announce its selection by the TEDDY (The Environmental Determinants of Diabetes in the Young) study to provide comprehensive antibody reactome services for their large…
Read More
Infinity Bio, Inc., a biotechnology company specializing in antibody reactome profiling, hosted a special community event aimed at engaging and inspiring Baltimore children with an interest in STEM. The event…
Read More
Infinity Bio, a technology company known for its innovative antibody reactome profiling service, will host an open house event at its state-of-the-art laboratory at 6200 Seaforth Street in Baltimore on…
Read More
Infinity Bio takes a business-to-business approach to pharmaceuticals. Here's more on the company and its growth.
Read More
Infinity Bio, Inc. announces its new antibody profiling platform, leveraging Molecular Indexing of Proteins by Self-Assembly (MIPSA) technology. This platform offers unparalleled depth in immune system analysis, advancing immunology, virology,…
Read More